About Dr. Nabil Dib
Nabil Dib, M.D., MSc,FACC is one of the world's most renowned cardiovascular researchers and doctors.
View Curriculum Vitae (requires Adobe® Reader®)
For nearly 20 years, Dr. Dib
has been conducting research and developing the newest investigational treatments for advanced cardiovascular disease.
is internationally known and respected for his
research and work regarding the use of adult stem cells to restore the health of patients with severe heart disease.
travels the world speaking at Cardiology events, conducting research and clinic trials and working to improve quality of life and survival for patients with cardiovascular disease.
Interventional Cardiology Fellowship Program at Harvard Medical School
, Beth-Israel-Deaconess Medical Center
also completed an additional year in Investigational Devices at Harvard Medical School
Additionally, he continued his education at Harvard School of Public Health, where he obtained a degree in Master of Science in Epidemiology and Research, concentrated on a clinical trial designed and effectiveness.
completed three years of General Cardiology at the University of Wisconsin
, Milwaukee Clinical Campus at Sinai Samaritan Medical Center
residency was in Internal Medicine at Tufts University School of Medicine
internship at Boston University
Dr. Dib received his Medical Degree from Damascus University School of Medicine in Damascus, Syria.
Currently, he is Director of Cardiovascular Research at Mercy Gilbert & Chandler Regional Medical Centers, members of Catholic Healthcare West (CHW).
He is also an Associate Professor of Medicine and Director of Clinical Cardiovascular Cell Therapy, University of California San Diego, Director of Heart Sciences Center, President and Founder of the International Society for Cardiovascular Translational Research and Editor in Chief of the Journal of Cardiovascular Translational Research.
As Director, Cardiovascular Research at Mercy Gilbert & Chandler Regional Medical Centers, Dr. Dib has led the charge for the healthcare industry to find innovative ways to utilize adult non-embryonic stem cells that may have the potential to restore the health of patients who have no other available treatments.
is internationally known for his
research and work with stem cell therapy.
did the first worldwide experiment to demonstrate the feasibility of stem cell transplantation using 3-D catheter guidance in February 2000 and a few months later he
implanted the first patient with stem cell therapy.
In 2004, he
obtained the first FDA approval in the United States for stem cell transplantation for patients with heart failure and heart attack using the 3-D catheter guidance technology, a minimally invasive procedure.
also authored a book on the topic titled, Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications.
Prior to joining Catholic Healthcare West, Dr. Dib formed Cardiovascular and Stem Cell Consultants (CSCC), a cardiology practice that provides the highest quality healthcare to patients with cardiovascular disease.
also provides patients access to the newest investigational treatments for advanced cardiovascular disease such as Adult Stem Cells, Gene Therapy, and New Devices, a very important program for personalized medicine.
Additional experience includes seven years at the Arizona Heart Institute in Phoenix, Ariz., where Dr. Dib was Director of Interventional Cardiovascular Research and Director of the Interventional Fellowship Program.
tenure with the Arizona Heart Institute
, Dr. Dib
was named America's Top Doctors for Interventional Cardiology in 2003.
Throughout his career, Dr. Dib has served on several advisory boards and steering committees including: Cordis/Johnson & Johnson, Schering/Berlex, Volcano Corp., POSSIS Medical Inc., and Cardiovascular System Inc.
In 2007, he was named Proctor, 3-D Mapping and stem cell transplantation for Biologics Delivery Systems/Cordis Corporation, a Johnson & Johnson Company.
has also been involved with numerous professional affiliations such as: the American Heart Association
, American College of Cardiology
, American College of Physicians
, International Society of Endovascular Intervention
and the Massachusetts Medical Society
In addition, Dr. Dib helped write the board exam for the American College of Cardiology and is a reviewer for several medical journals and publications.
research interests include Stem Cell Therapy for Myocardial Regeneration and Methods of Delivery, Genomics, Personalized Medicine, New Investigational Devices in Cardiology.
In addition, Dr. Dib
has done extensive work in the following areas: Stent Deployment, Doppler FloWire, Pressurewire, Intravascular Ultrasound, Valvuloplasty, Rotational Atherectomy, Directional Atherectomy, Beta-Radiation, Novoste, Possis Angiojet, PercuSurge GuardWire System, Angioseal, Perclose and Vasoseal.
To learn more about Dr. Dib's
accomplishments and recent media coverage, visit our Media Center.
Women's cholesterol levels tend to rise as they age.
Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair by Dr. Dib